Daixin Yin

631 citations
8 papers · 511 indexed · h-index 8
Topics
Global Cancer Incidence and Screening (5 papers)Pancreatic and Hepatic Oncology Research (3 papers)Colorectal Cancer Screening and Detection (2 papers)
Partner nations
United StatesChile

In The Last Decade

Daixin Yin

8 papers receiving 487 citations

Peers

Daixin Yin
Comparison fields: 5 of 85
  • Oncology 339
  • Epidemiology 102
  • Pulmonary and Respiratory Medicine 97
  • Surgery 92
  • Cancer Research 65
Replace Maria O. Celaya with:
Maria O. Celaya United States
A. Rana Bayakly United States
Caralee Roberts United States
Benjamin Barnes Germany
Kari Fish United States
Hiltraud Kajüter Germany
Mike Quinn United Kingdom
Antoinette Percy‐Laurry United States
Güngör Utkan Türkiye
Laëtitia Daubisse‐Marliac France
Daixin Yin relative to Maria O. Celaya United States Maria O. Celaya's profile →
Citations per field
00.5×1.6×
Maria O. Celaya · 1×
Citations per year

Countries citing papers authored by Daixin Yin

Since Specialization
Citations

This map shows the geographic impact of Daixin Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daixin Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daixin Yin more than expected).

Fields of papers citing papers by Daixin Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daixin Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daixin Yin. The network helps show where Daixin Yin may publish in the future.

Co-authorship network of co-authors of Daixin Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Daixin Yin. A scholar is included among the top collaborators of Daixin Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daixin Yin. Daixin Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 29
2 15
3 150
4 39
5
The impact of patient follow-up on population-based survival rates.
16
6 92
7 17
8 153

About Daixin Yin

Daixin Yin is a scholar working on Oncology, Health and Demography, having authored 8 papers that have together received 511 indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Oncology (339 citations), Health (48 citations) and Cancer Research (65 citations). Daixin Yin has collaborated with scholars based in United States and Chile. Frequent co-authors include Rosemary D. Cress, Richard J. Bold, Elizabeth A. Holly, Robert R. German, Aliza K. Fink, Jack L. Finch, Sherri L. Stewart, Melonie Heron, Chris J. Johnson and Lihua Liu. Their work appears in journals such as Cancer, Social Science & Medicine and Cancer Causes & Control.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026